prodchem
Aug 13, 2026
The second-quarter 2026 earnings season has produced several notable surprises across the global chemical industry. BASF's 167% year-over-year increase in net income, together with strong sales growth reported by Dow and LyondellBasell, highlights how dramatically market conditions shifted during the quarter.
BASF reported Q2 sales of €17.2 billion, up 16%, while EBITDA before special items reached €2.4 billion, significantly exceeding analyst expectations. However, the headline net-income increase was heavily influenced by a €3.9 billion gain from the sale of its coatings business to Carlyle, meaning the earnings jump needs to be separated from underlying operating performance.
Dow, meanwhile, reported $12.1 billion in Q2 sales, up 20% year over year, with higher prices—particularly in polyethylene—playing a major role.
Together, these results provide an important benchmark for understanding which chemical companies benefited most from the unusual pricing and supply conditions seen during Q2.
Chemical earnings are heavily influenced by commodity prices, feedstock costs, operating rates, inventories and global supply conditions.
That makes quarterly surprises particularly useful for identifying changes in the industry cycle.
The Q2 results can help investors and industry participants evaluate:
Pricing power
Demand resilience
Margin recovery
Supply-chain disruptions
Feedstock economics
Cost-cutting benefits
Regional supply imbalances
Management guidance
The most important question is whether the stronger results represent a temporary pricing event or the beginning of a broader earnings recovery.
BASF delivered one of the most dramatic headline earnings increases of the quarter.
Net income reached approximately €4.1 billion, compared with just €79 million in Q2 2025. However, the company made clear that the result was primarily affected by the €3.9 billion pretax disposal gain from the coatings transaction.
That makes BASF's result unusual.
The company's underlying operations also improved, but the headline 167% profit increase should not be interpreted as a comparable improvement in recurring chemical earnings.
Its EBITDA before special items increased to €2.4 billion, from €1.6 billion a year earlier, while sales increased 16% to €17.2 billion.
BASF's Q2 performance can be separated into three different signals.
The 167% increase in net income makes BASF one of the quarter's most dramatic earnings stories.
EBITDA before special items increased by €854 million year over year.
A large portion of the net-income increase came from the coatings disposal rather than recurring chemical operations.
This distinction is critical when comparing BASF with peers.
Dow's Q2 result is arguably more useful for assessing the underlying operating environment.
The company reported $12.1 billion of net sales, representing a 20% year-over-year increase. Local prices also increased 20%, while volume declined 1%.
That combination tells an interesting story.
Dow's improvement was driven primarily by pricing rather than volume growth.
The company reported higher prices across all regions, with particularly strong gains in Packaging & Specialty Plastics and polyethylene.
This suggests that supply conditions, rather than a broad-based surge in physical demand, played a major role in the earnings improvement.
One of the clearest themes across the strongest Q2 results is pricing.
BASF reported an 11.5% increase in prices and a 7.3% increase in volumes.
Dow reported a 20% increase in local prices alongside a 1% volume decline.
That contrast is revealing.
BASF benefited from both price and volume improvements.
Dow benefited overwhelmingly from pricing.
For the broader industry, this raises an important question:
Can higher prices persist once supply conditions normalize?
The Q2 chemical market was heavily influenced by supply disruptions connected with the Middle East.
Disruptions to energy and petrochemical supply created tighter availability for certain products and changed regional pricing dynamics.
For producers with available inventories, integrated feedstock positions or exposure to affected product chains, this created an unusual earnings tailwind.
That helps explain why several chemical companies performed better than expectations despite an otherwise uneven demand environment.
Not every chemical company benefited equally.
Some producers continued to face:
Weak underlying demand
High fixed costs
Excess capacity
Weak regional pricing
Inventory pressure
Expensive feedstocks
Restructuring costs
This makes the Q2 earnings season particularly useful for comparing winners and laggards rather than treating the entire industry as one market.
BASF and Dow illustrate two different forms of earnings improvement.
Higher prices + higher volumes + portfolio gains + disposal gain
Higher prices + cost initiatives + favorable product pricing
The distinction matters because BASF's headline net-income increase was substantially influenced by a transaction-related gain, while Dow's sales improvement was primarily operational.
Featured Product
A large earnings increase does not automatically mean that a company's underlying business has improved by the same magnitude.
Investors should separate:
Recurring operating performance
from
One-time financial effects
BASF is a textbook example.
The €3.9 billion coatings disposal gain dramatically increased reported net income, but it does not represent recurring chemical-sector profitability.
The more useful recurring indicator is therefore EBITDA before special items.
Despite the distortion created by the disposal gain, BASF's operating performance was clearly stronger.
EBITDA before special items increased from €1.6 billion to €2.4 billion, while EBIT before special items increased from €0.7 billion to €1.5 billion.
The company also raised its full-year 2026 EBITDA-before-special-items outlook to €6.9 billion–€7.7 billion, compared with its previous range of €6.2 billion–€7.0 billion.
That guidance increase is arguably a more important recovery signal than the headline net-income jump.
Dow's Q2 performance also demonstrates how quickly chemical earnings can change when pricing improves.
Operating EBIT reached $1.6 billion, compared with a loss in the year-ago period, while operating EPS rose to $1.44 from a loss of $0.42.
The company attributed the improvement primarily to higher prices and its self-help initiatives.
That combination provides a useful benchmark for evaluating other commodity chemical producers.
The Dow numbers also contain a cautionary detail.
Despite 20% higher sales, volumes declined 1% year over year.
That means the earnings improvement cannot simply be interpreted as evidence of booming demand.
If prices remain elevated while volumes stay weak, the industry's recovery may still be fragile.
The biggest intelligence takeaway from the earnings season may therefore be the divergence between price recovery and volume recovery.
Prices improved sharply.
Volumes were much less impressive.
That suggests the chemical industry may be experiencing a supply-driven earnings rebound rather than a pure demand-driven recovery.
Producers benefiting from stronger pricing have an opportunity to rebuild margins.
However, they also need to determine whether the improvement is sustainable.
Management teams should consider:
Capacity utilization
Customer inventory levels
Contract repricing
Feedstock costs
Regional supply balances
Export competition
New capacity additions
If supply disruptions disappear, pricing could weaken again.
For chemical buyers, the Q2 earnings results are equally important.
Higher producer prices can eventually translate into higher purchasing costs.
Procurement teams should therefore:
Track producer pricing announcements
Monitor regional supply disruptions
Review contract formulas
Compare spot and contract markets
Diversify suppliers
Maintain inventory flexibility
Watch for normalization in pricing
A temporary pricing spike should not automatically become the basis for long-term procurement assumptions.
Another recurring theme in Q2 results is the contribution from internal efficiency programs.
Chemical producers have spent much of the downcycle reducing costs, rationalizing assets and improving productivity.
When prices recover, those savings can have an outsized effect on earnings.
A producer with a leaner cost structure can therefore see profits rise much faster than sales.
The Q2 results increasingly suggest a two-speed chemical sector.
Companies benefiting from:
Pricing improvements
Supply tightness
Cost reductions
Integrated operations
Favorable product exposure
Companies still exposed to:
Structural oversupply
Weak demand
High operating costs
Excess capacity
Difficult regional markets
This divergence will likely become more important as the 2026 cycle develops.
The 167% net-income increase is among the most dramatic headline improvements, although the disposal gain makes the comparison unusually difficult.
A 20% year-over-year sales increase, combined with a sharp improvement in operating earnings, represents one of the stronger operational performances among major commodity chemical producers.
The 50% increase in EBITDA before special items provides a cleaner indicator of operating improvement than the headline net-income figure.
Double-digit price increases at major producers suggest that supply conditions played an unusually important role in Q2 performance.
The next quarter will reveal whether the Q2 earnings surprise was sustainable.
Key indicators include:
Chemical selling prices
Producer margins
Volume growth
Operating rates
Inventory normalization
Middle East supply conditions
Feedstock prices
New capacity
Plant closures
The most important test will be whether earnings remain strong after the exceptional supply conditions of Q2 fade.
Q2 2026 produced some of the chemical industry's most striking earnings surprises in recent years.
BASF's headline net-income increase was extraordinary, but its underlying EBITDA improvement provides a more useful measure of operating recovery. Dow's 20% sales increase similarly demonstrates the power of higher pricing, even though volumes declined slightly.
The broader lesson is that 2026's chemical earnings recovery is not being driven by one factor.
Pricing, supply disruptions, cost reductions and portfolio actions are all contributing.
That makes the next phase of the cycle particularly important.
If volumes begin accelerating alongside higher prices, the Q2 results could represent the beginning of a genuine sector recovery.
If prices retreat while volumes remain weak, the quarter may instead prove to have been a temporary supply-driven earnings spike.
For investors, producers and procurement professionals, that distinction will be one of the most important chemical-sector intelligence questions to monitor through the second half of 2026.
BASF's Q2 net income increased approximately 167% year over year, making it one of the quarter's largest headline earnings surprises.
BASF's result was heavily influenced by a €3.9 billion pretax gain from the coatings transaction, making EBITDA before special items a better measure of recurring performance.
BASF's EBITDA before special items increased to €2.4 billion, from €1.6 billion a year earlier.
Dow reported $12.1 billion of Q2 sales, up 20% year over year.
Dow's improvement was driven largely by higher prices, while volumes declined 1%.
Supply disruptions and pricing were major contributors to the quarter's strongest chemical-sector performances.
The sustainability of the earnings recovery will depend on whether volume growth eventually follows the improvement in pricing.
Investors should distinguish temporary supply-driven gains from durable improvements in underlying chemical demand.
Found this useful?
Continue Reading
Shinsung Materials has patented technology for producing and stabilizing water-soluble UV filters, targeting a key formulation challenge in sunscreen and personal care products. The innovation could support more stable specialty ingredients for formulators and buyers.
Petrochemical gains have strengthened earnings at major producers as Middle East supply disruptions tighten global markets. Buyers and investors now face a key question: can stronger pricing and margins survive into 2027?
Rising cracking margins are reinforcing the same supply dynamics supporting polymer producers as damaged Middle East capacity tightens global availability. Buyers now face a market where feedstock economics, operating rates and regional supply risks increasingly move together.
